TDC
PTX

Thompson Davis & Co’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Thompson Davis & Co’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,027
Closed -$60K – 1252
2015
Q4 		$60K Sell
2,027
-250
-11% -$7.56K 0.08% 228
2015
Q3 		$72K Sell
2,277
-975
-30% -$46.6K 0.1% 201
2015
Q2 		$193K Sell
3,252
-13,855
-81% -$977K 0.22% 100
2015
Q1 		$1.83M Buy
17,107
+1,631
+11% +$155K 2.2% 4
2014
Q4 		$1.45M Sell
15,476
-12,187
-44% -$1.16M 1.68% 6
2014
Q3 		$2.13M Buy
27,663
+14,321
+107% +$1.13M 2.74% 2
2014
Q2 		$1.32M Buy
13,342
+5,242
+65% +$321K 1.9% 2
2014
Q1 		$433K Buy
+8,100
New +$267K 0.72% 33

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Thompson Davis & Co's PTX Position: Q1 2016 in Review

Thompson Davis & Co sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 2,027 shares — an estimated $60K sold.

Thompson Davis & Co first reported a position in PTX in Q1 2014 and held it in 8 quarters. The position peaked at $2.13M in Q3 2014. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

  • Thompson Davis & Co reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 2,027 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $60K.
  • Thompson Davis & Co first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 8 quarters.
  • Thompson Davis & Co's Pernix Therapeutics Holdings, Inc. position peaked at $2.13M in Q3 2014.
  • 88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Thompson Davis & Co's 13F filing for Q1 2016, filed 2 May 2016.